4SC's IPO

4SC raised a round of funding on October 24, 2005. Investors include Public.

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovati…

Articles about 4SC's IPO: